North Growth Management’s Pfizer PFE Stock Holding History

North Growth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-252,960	Closed	-$7.86M	–	48
2020 Q2	$7.86M	Sell	252,960 -8,432	-3%	-$286K	1.88%	27
2020 Q1	$8.08M	Buy	261,392 +31,620	+14%	+$1.08M	2.27%	18
2019 Q4	$8.54M	Hold	229,772	–	–	1.92%	28
2019 Q3	$7.84M	Buy	229,772 +1,054	+0.5%	+$38.3K	1.89%	25
2019 Q2	$9.38M	Hold	228,718	–	–	2.32%	21
2019 Q1	$9.2M	Hold	228,718	–	–	2.46%	18
2018 Q4	$9.46M	Sell	228,718 -107,508	-32%	-$4.46M	2.64%	16
2018 Q3	$14.1M	Hold	336,226	–	–	3.56%	5
2018 Q2	$11.6M	Buy	336,226 +35,836	+12%	+$1.22M	2.92%	8
2018 Q1	$10.1M	Hold	300,390	–	–	2.6%	15
2017 Q4	$10.3M	Buy	+300,390	New	+$10.2M	2.7%	15

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

North Growth Management's PFE Position: Q3 2020 in Review

North Growth Management sold out of Pfizer (PFE) in Q3 2020, closing a stake of 252,960 shares — an estimated $7.86M sold.

North Growth Management first reported a position in PFE in Q4 2017 and held it in 11 quarters. The position peaked at $14.1M in Q3 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

North Growth Management reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
North Growth Management sold 252,960 Pfizer shares in Q3 2020, an estimated $7.86M.
North Growth Management first reported a position in Pfizer in Q4 2017 and held it in 11 quarters.
North Growth Management's Pfizer position peaked at $14.1M in Q3 2018.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on North Growth Management's 13F filing for Q3 2020, filed 4 Nov 2020.